Halaman 11 - Dokter Terbaik di Israel — Dapatkan Konsultasi Online

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. David (Dudi) Mishali, MD, is Director of Pediatric and Congenital Cardiothoracic Surgery at Sheba Medical Center. He treats infants and children with congenital heart defects. His work includes rare, high-risk anomalies and complex newborn reconstructions.

He trained internationally. He completed his residency at Rabin Medical Center and clinical fellowships in cardiac surgery at the Cleveland Clinic and in congenital pediatric cardiothoracic surgery at UCSF. He is board certified in cardiothoracic surgery. He developed and implemented minimally invasive methods that reduce surgical trauma and improve cosmetic results.

He is a Senior Lecturer at Tel Aviv University’s Sackler Faculty of Medicine. He has written many peer-reviewed papers and book chapters, including on point-of-care testing in children during cardiopulmonary bypass and on accessory mitral valve tissue. He holds a leadership role at a hospital ranked among the world’s top 10.

Prof. Roy Mashiach, MD, is the Director of Gynecology at Sheba Medical Center. He is a leading expert in minimally invasive gynecologic surgery with over 30 years of experience. He focuses on laparoscopic and hysteroscopic hysterectomy. He also performs myoma removal, treats endometriosis, and offers fertility‑preserving procedures.

Recognition and roles: Named to Forbes Israel’s Best Doctors. Recipient of the Daniel F. Kott Award (AAGL). Chairman of the Israeli Society of Gynecological Endoscopy. Director of the Gynecologic Simulation Unit (M.S.R.). Clinical Associate Professor at Tel Aviv University. Training: MD from Tel Aviv University. Specialization at Lis Maternity & Women’s Hospital. Fellowship in Advanced Endoscopy at Université d’Auvergne.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dokter adalah Kepala Departemen Urologi di Pusat Medis "Assaf Harofeh", yang mengkhususkan diri dalam operasi kompleks yang melibatkan ginjal, prostat, dan kandung kemih. Dokter mahir dalam mendiagnosis dan merawat adenoma prostat, termasuk penggunaan teknologi laser.<\/p>

Dididik di Universitas Tel Aviv dan UCLA, dokter adalah anggota dari beberapa organisasi bergengsi, termasuk Asosiasi Ahli Bedah Israel, Asosiasi Urologi Amerika, Eropa, dan Israel, serta Asosiasi Endourologi. Selain itu, dokter menjabat sebagai Ketua Dewan Serikat Dokter Israel.<\/p>

Dokter ini berspesialisasi dalam hematologi dengan fokus pada pengobatan limfoma. Dengan pengalaman luas di bidang ini, dokter telah berkontribusi secara signifikan terhadap kemajuan dalam pengobatan limfoma dan perawatan pasien. Dokter diakui atas keahliannya dan komitmennya untuk meningkatkan hasil bagi pasien dengan gangguan hematologi.<\/p>

Dokter adalah spesialis dalam bedah laparoskopi dan bariatrik, menawarkan keahlian dalam teknik bedah invasif minimal. Dengan fokus pada peningkatan hasil pasien, dokter telah berkontribusi pada kemajuan dalam prosedur bedah dan telah diakui atas keunggulannya di bidang ini. Dokter berdedikasi untuk memberikan perawatan berkualitas tinggi dan memiliki rekam jejak yang kuat dalam operasi yang sukses, meningkatkan keselamatan pasien dan waktu pemulihan.<\/p>

Dokter adalah seorang ahli profesional dalam bedah vaskular di Aya Medical, Rumah Sakit Assuta, Tel Aviv, yang berspesialisasi dalam perawatan lanjutan untuk varises dan penyakit endovaskular. Dengan menggunakan metode inovatif seperti laser dan frekuensi radio, uap, teknologi ClariVein, dan skleroterapi, dokter telah mengembangkan teknik unik di bidang ini.<\/p>

Lulus dari Fakultas Kedokteran di Universitas Tel Aviv, dokter menyelesaikan magang dalam Bedah Umum di Rumah Sakit Meir dan lebih lanjut mengkhususkan diri dalam bedah vaskular di Pusat Medis Suraski, dengan pelatihan tambahan di Inggris, Jerman, dan Amerika Serikat.<\/p>

Dokter adalah penulis produktif publikasi ilmiah dan peserta aktif dalam konferensi Israel dan internasional.<\/p>

Dokter ini mengkhususkan diri dalam Kebidanan, Ginekologi, dan Onkoginekologi, dengan fokus pada perawatan dan pengobatan komprehensif kesehatan reproduksi wanita. Keahlian klinis mencakup pengelolaan kehamilan berisiko tinggi, melakukan operasi ginekologi lanjutan, dan memberikan perawatan onkologi khusus untuk kanker ginekologi. Dokter ini diakui atas kontribusinya dalam kemajuan teknik bedah minimal invasif dan telah menerbitkan banyak artikel penelitian di jurnal yang ditinjau sejawat. Dokter ini juga aktif terlibat dalam pendidikan medis, membimbing generasi berikutnya dari profesional kesehatan.<\/p>

Dokter adalah seorang ahli bedah kardiotoraks yang sangat berpengalaman dengan fokus pada operasi jantung yang kompleks. Mereka telah melakukan lebih dari 2.000 operasi jantung yang berhasil, mengkhususkan diri dalam teknik minimal invasif dan perawatan jantung lanjutan. Dokter ini bersertifikat dalam bedah kardiotoraks dan telah berkontribusi pada banyak jurnal yang ditinjau sejawat, memajukan bidang bedah jantung. Mereka telah diakui atas pendekatan inovatif mereka dalam mengobati cacat jantung bawaan dan secara aktif terlibat dalam penelitian dan uji klinis.<\/p>

Dokter adalah spesialis dalam Obstetri dan Ginekologi, dengan pengalaman luas dalam menangani kehamilan berisiko tinggi dan melakukan operasi ginekologi lanjutan. Dokter telah berkontribusi pada banyak jurnal yang ditinjau sejawat dan merupakan anggota dari beberapa masyarakat medis bergengsi. Dengan fokus pada perawatan yang berpusat pada pasien, dokter telah berhasil memimpin inisiatif untuk meningkatkan hasil kesehatan ibu. Selain itu, dokter secara aktif terlibat dalam penelitian klinis dan pendidikan, membimbing generasi berikutnya dari para profesional kesehatan.<\/p>